Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model - PubMed (original) (raw)

Comparative Study

Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model

R Scott Rector et al. Am J Physiol Gastrointest Liver Physiol. 2011 May.

Abstract

The maintenance of normal body weight either through dietary modification or being habitually more physically active is associated with reduced incidence of nonalcoholic fatty liver disease (NAFLD). However, the means by which weight gain is prevented and potential mechanisms activated remain largely unstudied. Here, we sought to determine the effects of obesity prevention by daily exercise vs. caloric restriction on NAFLD in the hyperphagic, Otsuka Long-Evans Tokushima Fatty (OLETF) rat. At 4 wk of age, male OLETF rats (n = 7-8/group) were randomized to groups of ad libitum fed, sedentary (OLETF-SED), voluntary wheel running exercise (OLETF-EX), or caloric restriction (OLETF-CR; 70% of SED) until 40 wk of age. Nonhyperphagic, control strain Long-Evans Tokushima Otsuka (LETO) rats were kept in sedentary cage conditions for the duration of the study (LETO-SED). Both daily exercise and caloric restriction prevented obesity and the development of type 2 diabetes observed in the OLETF-SED rats, with glucose tolerance during a glucose tolerance test improved to a greater extent in the OLETF-EX animals (30-50% lower glucose and insulin areas under the curve, P < 0.05). Both daily exercise and caloric restriction also prevented excess hepatic triglyceride and diacylglycerol accumulation (P < 0.001), hepatocyte ballooning and nuclear displacement, and the increased perivenular fibrosis and collagen deposition that occurred in the obese OLETF-SED animals. However, despite similar hepatic phenotypes, OLETF-EX rats also exhibited increased hepatic mitochondrial fatty acid oxidation, enhanced oxidative enzyme function and protein content, and further suppression of hepatic de novo lipogenesis proteins compared with OLETF-CR. Prevention of obesity by either daily exercise or caloric restriction attenuates NAFLD development in OLETF rats. However, daily exercise may offer additional health benefits on glucose homeostasis and hepatic mitochondrial function compared with restricted diet alone.

PubMed Disclaimer

Figures

Fig. 1.

Fig. 1.

Weekly food consumption (A) and body weight gain (B). Values are means ± SE (n = 6–8 animals in each group). *Otsuka Long-Evans Tokushima Fatty sedentary (OLETF-SED) significantly different from other animal groups at respective ages (P < 0.001). Inset, values with different superscripts are significantly different (P < 0.001). OLETF-EX, exercised OLETF rats; LETO-SED, sedentary Long-Evans Tokushima Otsuka rats; OLETF-CR, calorie-restricted OLETF rats.

Fig. 2.

Fig. 2.

Systemic glucose homeostasis as assessed by an intraperitoneal glucose tolerance test. Glucose responses across time (A), glucose area under curve (AUC; B), insulin responses across time (C), and insulin AUC (D). Values are means ± SE (n = 5–6). Values with different superscripts are significantly different (P < 0.05).

Fig. 3.

Fig. 3.

Representative images of hematoxylin and eosin (H&E) (×10 and 40 fields of view; A and B), Oil-Red O (C), and picrosirius red (D) staining. Note the large lipid vacuoles (A and B), macro- and microvesicular steatosis (A-C), hepatocyte ballooning and nuclear displacement (A and B), and perivenular fibrosis (C) in the 40-wk-old OLETF-SED animals compared with the other animal groups.

Fig. 4.

Fig. 4.

Quantification of hepatic triglyceride (TG) and steatosis scores is shown in A and B and hepatic diacylglycerol (DAG) content is shown in C. Values are means ± SE (n = 6–8). Values with different superscripts are significantly different (P < 0.01).

Fig. 5.

Fig. 5.

Effects of daily exercise and caloric restriction on hepatic complete palmitate oxidation to CO2 (A), total mitochondrial palmitate oxidation [CO2 and acid soluble metabolites (ASMs); _B_], total extramitochondrial palmitate oxidation (C), total lignocerate oxidation (CO2 and ASMs; D), β-hydroxyacyl-CoA dehydrogenase (β-HAD) activity (E), and citrate synthase activity (F). Values are means ± SE (n = 6–8). Values with different superscripts are significantly different (P < 0.05).

Fig. 6.

Fig. 6.

Effects of daily exercise and caloric restriction on hepatic carnitine palmitoyl-CoA transferease (CPT)-1 protein content (A), peroxisome proliferator-activated receptor (PPAR)-α protein content (B), and oxidative phosphorylation (OXPHOS) complex I-V protein content (D). Representative Western blots are shown in C and E. Values are means ± SE (n = 6–8). Values with different superscripts are significantly different (P < 0.05). AU, arbitrary units; ACOX1, acyl-CoA oxidase 1; CYP4A, cytochrome _P_-450 A2.

Fig. 7.

Fig. 7.

Effects of daily exercise and caloric restriction on the following hepatic markers of de novo lipogenesis: acetyl-coenzyme A carboxylase (ACC, A), phospho (p)-ACC (B), fatty acid synthase (FAS, C), phospho-mammalian target of rapamycin (mTOR, D), sterol regulatory element binding protein 1c (SREBP-1c, E), and stearoyl-CoA desaturase-1 (SCD-1, F). Representative Western blots are shown in G. Values are means ± SE (n = 6–8). Values with different superscripts are significantly different (P < 0.05).

Similar articles

Cited by

References

    1. Asayama K, Sandhir R, Sheikh FG, Hayashibe H, Nakane T, Singh I. Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver. Mol Cell Biochem 194: 227–234, 1999 - PubMed
    1. Bass A, Brdiczka D, Eyer P, Hofer S, Pette D. Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem 10: 198–206, 1969 - PubMed
    1. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132: 112–117, 2000 - PubMed
    1. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147–152, 2004 - PMC - PubMed
    1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387–1395, 2004 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources